Showing results (1-10 of 36) with videos related to

Sort By:
Pageof 4
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|February 22, 2023
Analysis of Dynamic Efficacy Endpoints of the Nix-TB TrialBelén P Solans, Marjorie Z Imperial, Morounfolu Olugbosi, et al.
Clinical Pharmacology and Therapeutics|September 11, 2023
Population Pharmacokinetics and Pharmacodynamics of Pegozafermin in Patients with Nonalcoholic SteatohepatitisChih-Ming Leo Tseng, Kemal Balic, R Will Charlton, et al.
Antimicrobial Agents and Chemotherapy|January 8, 2020
Mechanistic Modeling of Mycobacterium tuberculosis Infection in Murine Models for Drug and Vaccine Efficacy StudiesNan Zhang, Natasha Strydom, Sandeep Tyagi, et al.
Annual Review of Pharmacology and Toxicology|August 19, 2020
Development of New Tuberculosis Drugs: Translation to Regimen Composition for Drug-Sensitive and Multidrug-Resistant TuberculosisJacqueline P Ernest, Natasha Strydom, Qianwen Wang, et al.
Open Forum Infectious Diseases|April 13, 2026
Impact of High-Dose Rifampicin on Linezolid Pharmacokinetics in Tuberculous MeningitisDvijen Purohit, Rob van Wijk, Paddy Kafeero, et al.
Annual Review of Pharmacology and Toxicology|September 30, 2021
Emerging Therapeutics, Technologies, and Drug Development Strategies to Address Patient Nonadherence and Improve Tuberculosis TreatmentMaria Garcia-Cremades, Belen P Solans, Natasha Strydom, et al.
CPT: Pharmacometrics & Systems Pharmacology|September 11, 2023
Combining pharmacometric models with predictive and prognostic biomarkers for precision therapy in Crohn's disease: A case study of brazikumabNan Zhang, Ming Liang Chan, Jing Li, et al.
Elife|November 15, 2018
High-resolution mapping of fluoroquinolones in TB rabbit lesions reveals specific distribution in immune cell typesLandry Blanc, Isaac B Daudelin, Brendan K Podell, et al.
Antimicrobial Agents and Chemotherapy|October 4, 2021
Comparative Efficacy of Rifapentine Alone and in Combination with Isoniazid for Latent Tuberculosis Infection: a Translational Pharmacokinetic-Pharmacodynamic Modeling StudyKendra K Radtke, Jacqueline P Ernest, Nan Zhang, et al.
Plos Medicine|May 1, 2019
Pharmacokinetics, optimal dosing, and safety of linezolid in children with multidrug-resistant tuberculosis: Combined data from two prospective observational studiesAnthony J Garcia-Prats, H Simon Schaaf, Heather R Draper, et al.
Pageof 4